_
Th

= ltem3of10 5 v Mark <q Se r j @ él fcc]

Question Id: 19309 Praras Next FullScreen Tutorial__—_Lab Values Notes

Researchers conducted a randomized controlled trial to assess the effectiveness of a new
drug to reduce severe cutaneous reactions in patients with rheumatoid arthritis who are treated
with adalimumab. Of 150 adults with rheumatoid arthritis who are treated with adalimumab, 75
received the new drug in addition to adalimumab, and 75 received a placebo in addition to
adalimumab. Results show that 6 patients in the new drug group developed severe cutaneous
reactions, compared to 9 in the placebo group. Which of the following represents the relative
risk reduction for severe cutaneous reactions among patients in the new drug group?

A. 0.08 (9%)
B. 0.10 (2%)
C. 0.12 (4%)

/ D.0.33 (61%)
E. 0.67 (22%)

Omitted
Correct answer lil

D

61% 04 secs c4 2022
Answered correctly Time Spent [3] Version

Block Time Elapse

Tutor

‘J

Calculator _ Reverse Color

GAA)

Text Zoom

Activate Windows

Feedback

id

63

Settings

End Block
